Cargando…
A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations
Anti-β-2 glycoprotein I antibodies (anti-B2GPI) are often cited as the major pathogenically relevant antibody in antiphospholipid syndrome (APS), but it is unclear if there is clinical evidence to support this theory. We performed a systematic review to determine if immunoglobulin G anti-B2GPI posit...
Autores principales: | Jiang, Debbie, Lim, Wendy, Crowther, Mark, Garcia, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945648/ https://www.ncbi.nlm.nih.gov/pubmed/34547773 http://dx.doi.org/10.1182/bloodadvances.2021005205 |
Ejemplares similares
-
Optimization of Unnicked β2-Glycoprotein I and High Avidity Anti-β2-Glycoprotein I Antibodies Isolation
por: Artenjak, Andrej, et al.
Publicado: (2014) -
Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
por: Melayah, Sarra, et al.
Publicado: (2022) -
Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS)
por: Asif, Saba, et al.
Publicado: (2022) -
Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes
por: Wu, Li, et al.
Publicado: (2022) -
Anti-β2-glycoprotein I/HLA-DR Antibody and Adverse Obstetric Outcomes
por: Tanimura, Kenji, et al.
Publicado: (2023)